The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE ® Arca ® Biotechnology Index... Show more
The 10-day RSI Indicator for FBT moved out of overbought territory on December 08, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 instances where the indicator moved out of the overbought zone. In of the 23 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Moving Average Convergence Divergence Histogram (MACD) for FBT turned negative on December 08, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FBT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
FBT broke above its upper Bollinger Band on November 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Momentum Indicator moved above the 0 level on December 19, 2025. You may want to consider a long position or call options on FBT as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FBT advanced for three days, in of 325 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 240 cases where FBT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Category Health
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NWKDX | 78.59 | 0.22 | +0.28% |
| Nationwide Geneva Small Cap Gr Instl Svc | |||
| RIBEX | 62.87 | 0.17 | +0.27% |
| American Funds Invmt Co of Amer R2E | |||
| DNLYX | 55.91 | 0.14 | +0.25% |
| BNY Mellon Active MidCap Y | |||
| GSVPX | 16.98 | 0.01 | +0.06% |
| Goldman Sachs Small/Mid Cap Equity P | |||
| FIKGX | 132.49 | N/A | N/A |
| Fidelity Advisor Semiconductors Z | |||
A.I.dvisor indicates that over the last year, FBT has been closely correlated with IBB. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if FBT jumps, then IBB could also see price increases.